ClouDr Group (9955) Stock Overview
Provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
9955 Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
ClouDr Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.16 |
| 52 Week High | HK$2.05 |
| 52 Week Low | HK$0.91 |
| Beta | 0.33 |
| 1 Month Change | -10.77% |
| 3 Month Change | -30.54% |
| 1 Year Change | -7.20% |
| 3 Year Change | -92.41% |
| 5 Year Change | n/a |
| Change since IPO | -95.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9955 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 3.6% | 2.9% | 1.8% |
| 1Y | -7.2% | -10.6% | 39.6% |
Return vs Industry: 9955 exceeded the Hong Kong Healthcare industry which returned -10.6% over the past year.
Return vs Market: 9955 underperformed the Hong Kong Market which returned 39.6% over the past year.
Price Volatility
| 9955 volatility | |
|---|---|
| 9955 Average Weekly Movement | 7.7% |
| Healthcare Industry Average Movement | 5.8% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in HK Market | 14.7% |
| 10% least volatile stocks in HK Market | 3.2% |
Stable Share Price: 9955 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 9955's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 966 | Ming Kuang | www.cloudr.cn |
ClouDr Group Limited provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company’s integrated in-hospital solution offers an AI-driven extensive hospital SaaS to assist doctors in diagnosis and treatment, and to help enhance the doctor education; chronic condition management solution to hospitals, including hospital SaaS and proprietary artificial intelligence of things devices. It also offers pharmacy SaaS, which enables in-store, real-time online consultation, prescription, and risk pooling of outpatient services; and sells chronic condition related drugs based on its data insights in pharmacies, including information on inventory, sales, and shipments of prescription drugs.
ClouDr Group Limited Fundamentals Summary
| 9955 fundamental statistics | |
|---|---|
| Market cap | HK$749.03m |
| Earnings (TTM) | -HK$1.04b |
| Revenue (TTM) | HK$2.47b |
Is 9955 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9955 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.26b |
| Cost of Revenue | CN¥1.50b |
| Gross Profit | CN¥755.69m |
| Other Expenses | CN¥1.71b |
| Earnings | -CN¥949.68m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.47 |
| Gross Margin | 33.50% |
| Net Profit Margin | -42.10% |
| Debt/Equity Ratio | 65.1% |
How did 9955 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/17 02:18 |
| End of Day Share Price | 2025/11/17 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ClouDr Group Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Liping Zhao | China International Capital Corporation Limited |
| null null | CMB International Securities Limited |
| Jessie Lu | HSBC |
